Origo, a prominent DeSci platform on Base, has unveiled DCPlus, a biotech initiative featuring a patented transdermal gas therapy patch designed to enhance wound healing and tissue regeneration. Starting October 17, 2025, users can acquire $DCPLUS tokens through Origo Hub for staking, trading, or purchasing health products. The project integrates real-world biotechnology with blockchain utility, offering 2% of tokens for staking rewards and implementing a token buyback plan to maintain ecosystem stability.
Origo Launches DCPlus Biotech Project on Base with $DCPLUS Token
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.